SAM.GOV SOLICITATIONNoneAward NoticePSC AB12

RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

Official federal contracting solicitation issued by DEPT OF DEFENSE.

Notice ID75A50126C00010Official solicitation number
Response DeadlineOpenProposal submission cutoff
NAICS & PSC541714 / AB12View NAICS Hub →
Set-Aside StatusNoneCompetition designation
⚡ Shred RFP & Draft Proposal with AI →View Authoritative Notice on SAM.gov ↗
PURSUIT QUALIFICATION BRIEF · NOTICE 75A50126C00010

Analyze Solicitation & Generate Compliant Proposal Draft

BidGovAI automatically analyzes Section C (Statement of Work), extracts Section L & M scoring criteria, and tailors a win-themed technical response.

Pursuit Fit Score88% MATCHBased on 541714 & None
RFP Shredder & Matrix

Extracts all Section L & M compliance requirements into a traceable response matrix in ~45 seconds.

FAR Clause Scanner

Detects flow-down clauses, limitation on subcontracting (52.219-14), and CMMC cybersecurity mandates.

Turnaround Acceleration

Cuts proposal production from 30+ manual hours to under 4 hours with tailored technical narratives.

⚡ Start 14-Day Free Trial — Shred this RFP Now →🔒 $0.00 due today • Includes full Solicitation Shredder, Compliance Matrix & 1-click proposal workspace

Contracting Officer & Buyer Contact Information

Official government points of contact registered for this procurement. Use for pre-proposal questions, capability statements, and formal inquiries.

Primary Contracting Officer
Erin Greninger, Contracting Officer
Contracting Officer
Secondary Point of Contact / Specialist
Greg Smith
Contract Specialist

Contract Classification & Agency Hierarchy

DEPARTMENTDEPT OF DEFENSE
PLACE OF PERFORMANCE📍 Washington, DC, 20024, USA
PRODUCT SERVICE CODE (PSC)AB12
NAICS CODE541714
SET-ASIDE PROGRAMNone
Official Attachments: Download Solicitation Package & Attachments from SAM.gov ↗

Solicitation Statement of Work & Requirements

Scope of Work & Buyer Summary

This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.

Ready to Respond to this Solicitation?

BidGovAI extracts all compliance criteria, flags dangerous contract clauses (FAR 52.219-14, CMMC, Buy American), and drafts win themes aligned directly with the evaluator.

Start Free 14-Day Trial — Analyze this Opportunity →